Thomas Braxton King's Net Worth

-$583 Thousand

Estimate Recalculated Jul 8, 2024 04:47PM EST

Who is Thomas Braxton King?

Thomas Braxton King does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alexza Pharmaceuticals Inc., Satsuma Pharmaceuticals, Inc., ACHIEVE LIFE SCIENCES, INC., VIVUS INC, TFF Pharmaceuticals, Inc., and ORPHAN MEDICAL INC.

SEC CIK

Thomas Braxton King's CIK is 0001279309

Past Insider Trading and Trends

2011 was Thomas Braxton King's most active year for acquiring shares with 9 total transactions. Thomas Braxton King's most active month to acquire stocks was the month of June. 2008 was Thomas Braxton King's most active year for disposing of shares, totalling 24 transactions. Thomas Braxton King's most active month to dispose stocks was the month of January. 2013 saw Thomas Braxton King paying a total of $1,132,201.28 for 614,113 shares, this is the most they've acquired in one year. In 2007 Thomas Braxton King cashed out on 28,210 shares for a total of $204,413.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Alexza Pharmaceuticals Inc. No price found

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-77.22K
—
—
0
Jun 21
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Jul 22
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4/A
+22.86%
40K
$4.48
$179,350.64
215K
Jul 24 - Jul 26
Form 4
+22.86%
40K
$4.48
$179,350.64
215K
Jul 24 - Jul 26
Form 4
—
0
—
—
0
Form 4
∞
175K
$4.42
$773,500.00
175K
Mar 29
Form 4
—
0
—
—
30.15K
Feb 25
Form 4
—
0
—
—
0
Form 4
-25.26%
-10.00K
$4.14
-$41,364.00
29.59K
Scheduled
Aug 14 - Aug 27
Form 4
—
0
—
—
0
Jul 26
Form 4
-24.46%
-65.52K
$0.34
-$22,150.96
202.32K
Scheduled
Jun 6
Form 4
+59.58%
100K
—
—
267.84K
May 10
Form 4/A
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
+64.03%
65.52K
—
—
167.84K
Mar 23
Form 4
—
0
—
—
0
Jul 28
Form 4
—
0
—
—
289.46K
May 27
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Feb 22
Form 4
+814.43%
91.14K
—
—
102.33K
Jan 19
Form 4
—
0
—
—
196.37K
Dec 2
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Dec 28
Form 4/A
-37.24%
-45.00K
$2.23
-$100,284.73
75.84K
Scheduled
Dec 16 - Dec 18
Form 4
-37.23%
-44.99K
$2.23
-$100,271.34
75.85K
Scheduled
Dec 16 - Dec 18
Form 4
+115.06%
64.66K
$2.32
$149,999.60
120.84K
Oct 5
Form 4
+662.62%
48.82K
—
—
56.19K
Feb 24
Form 4
—
0
—
—
0
Jan 22
Form 4
-9.72%
-12.50K
$5.67
-$70,902.50
116.11K
Scheduled
Aug 11
Form 4
—
0
—
—
0
Jul 9
Form 4
-8.86%
-12.50K
$6.12
-$76,476.00
128.61K
Scheduled
May 12
Form 4
—
0
—
—
0
Form 4
-8.14%
-12.50K
$6.66
-$83,306.08
141.11K
Scheduled
Feb 11
Form 4
—
0
—
—
0
Jan 4
Form 4
-1.60%
-2.50K
—
—
153.61K
Dec 17
Form 4
-7.41%
-12.50K
$7.20
-$90,000.00
156.11K
Scheduled
Nov 9
Form 4
—
0
—
—
0
Form 4
-0.26%
-435.00
—
—
168.61K
Aug 23
Form 4
-6.89%
-12.50K
$9.15
-$114,413.00
169.04K
Scheduled
Aug 8 - Aug 9
Form 4
—
0
—
—
0
Jul 24
Form 4
—
0
—
—
0
Form 4
-0.15%
-275.00
—
—
181.54K
Mar 14
Form 4
—
0
—
—
0
Jan 4
Form 4
-66.24%
-2.07K
—
—
1.05K
Dec 21
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Aug 29
Form 4
—
0
—
—
0
Mar 13
Form 3
—
0
—
—
0
No matching records found

Satsuma Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Dec 3
Form 4
—
0
—
—
0
Jun 12
Form 3
—
0
—
—
0
No matching records found

ACHIEVE LIFE SCIENCES, INC. (ACHV) Snapshot price: $4.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Mar 29
Form 4
—
0
—
—
0
Mar 29
Form 3
—
0
—
—
0
No matching records found

VIVUS INC No price found

Interim Chief Executive Office

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 20
Form 4
—
0
—
—
0
Oct 26
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jul 27
Form 3
—
0
—
—
0
No matching records found

TFF Pharmaceuticals, Inc. (TFFP) Snapshot price: $5.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.58K
—
—
1.58K
Jul 3
Form 4
—
0
—
—
0
Apr 18
Form 4
—
0
—
—
0
Dec 13
Form 3
—
0
—
—
0
No matching records found